Clinical Trials Logo
  1. Home
  2. ASCVD
  3. NCT03400800

Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol — ORION-11  

Risk Factor, Cardiovascular Clinical Trial

Official title:
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) or ACSVD Risk-Equivalents and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

Clinical Trial Summary

This is a Phase III, placebo-controlled, double-blind, randomized study in participants with ASCVD or ASCVD-Risk equivalents and elevated LDL-C despite maximum tolerated dose of LDL-C lowering therapies to evaluate the efficacy, safety, and tolerability of subcutaneous (SC) inclisiran injection(s). The study will be an international multicenter study (non-United States).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03400800
Study type Interventional
Source The Medicines Company
Contact
Status Completed
Phase Phase 3
Start date November 1, 2017
Completion date August 27, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT03236597 - Assessing the Effects Of Treadmill On LPA, Sitting Time, and Cardiovascular Risk N/A
Recruiting NCT03065413 - It is a Prospective Study Aiming to Identify Incidence and Prevalence of Cardiovascular Diseases, Changes in Physical Activity, Dietary Habits and Anxiety Depression Levels Through a Period of Time in the Naval Personnel (PrOspeCtive HEllenic NAval PersoNnel StUdy in CardiovaScular Diseases) N/A
Completed NCT04739280 - Women's Assessed Cardiovascular Evaluation With MCG
Completed NCT04553614 - Home-based HIIT in a Primary-care Setting for at Risk Individuals: A Multidisciplinary Approach N/A
Withdrawn NCT03732417 - Telematic Model Integrated in the Transversal Care of the Secondary Prevention of Patients With Stroke
Completed NCT04709120 - Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection
Completed NCT04927871 - Hybridized Three Steps Intervention to Prevent Diabetes in Venezuela N/A
Completed NCT03698786 - Exercise Effects on Appetite-regulating Hormones and Cardiovascular Risk Factors
Active, not recruiting NCT03436238 - Myocardial Injury in Noncardiac Surgery in Sweden
Completed NCT02373319 - Self-screening of Cardiovascular Risk N/A
Completed NCT04542954 - Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East
Completed NCT03154502 - Sodium Intake in Ecuadorian Population N/A
Recruiting NCT02998788 - Risk Evaluation and Management in Heart Failure N/A
Completed NCT04026737 - Cardiovascular Effects of CART Cell Therapy
Completed NCT03282747 - Distribution of Risk Factors for Venous Thromboembolism in Blood Donors
Completed NCT03111420 - Study of AggreGuide A-100 (ADP) Assay N/A
Not yet recruiting NCT02989077 - Risk Profiling for Patients With Isolated or Combined Coronary and Cerebral Ischemia, and Current Management Status N/A
Completed NCT04580017 - Prognostic Accuracy of the HEART Score in Undifferentiated Chest Pain: A Multicenter Validation Study
Active, not recruiting NCT03925844 - Cardiovascular Risk in People Older Than 55 Years and Cognitive Performance at 5 Years
Completed NCT04306822 - Epidemiology of Cardiovascular Diseases and Their Risk Factors in Regions of Russian Federation